Literature DB >> 2760604

Cholecystokinin binding sites in the rat forebrain: effects of acute and chronic methamphetamine administration.

T Suzuki1, T Moroji.   

Abstract

Using the in vitro quantitative receptor autoradiographical technique, changes in the binding parameters of [propionyl-3H] propionylated CCK-8 [( 3H]pCCK-8) binding sites in the rat forebrain were investigated following acute and chronic administration of methamphetamine (MAP). The (Kd)app values of [3H]pCCK-8 binding sites in the frontal medial cortex and anterior cingulate cortex were significantly reduced after a single injection of 4mg/kg MAP. On the other hand, chronic treatment (14 days) with MAP at this dose significantly decreased the Bmax value of [3H]pCCK-8 binding sites in the anterior cingulate cortex accompanied by supersensitivity of locomotor effects to MAP. These findings suggest that dopamine (DA) neurons in these two regions are functionally related to intrinsic CCK-containing cortical neurons, and that CCK subsensitivity, perhaps due to an alteration in DA transmission, is involved in MAP sensitization. These findings may be relevant to the DA hypothesis of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2760604     DOI: 10.1007/BF01248931

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  54 in total

Review 1.  The dopamine hypothesis of schizophrenia: a review.

Authors:  H Y Meltzer; S M Stahl
Journal:  Schizophr Bull       Date:  1976       Impact factor: 9.306

2.  Electrophysiological studies of the role of cholecystokinin in the substantia nigra and its interactions with dopamine.

Authors:  L R Skirboll; D W Hommer
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

3.  Possible circadian and seasonal rhythmicity in an in vitro model: monoamine uptake in rat brain slices.

Authors:  A Wirz-Justice
Journal:  Experientia       Date:  1974-11-15

4.  Efferent connections of the cingulate gyrus in the rhesus monkey.

Authors:  D N Pandya; G W Van Hoesen; M M Mesulam
Journal:  Exp Brain Res       Date:  1981       Impact factor: 1.972

5.  Distinct cholecystokinin receptors in brain and pancreas.

Authors:  R B Innis; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

6.  Continuous amphetamine intoxication: an animal model of the acute psychotic episode.

Authors:  G D Ellison; M S Eison
Journal:  Psychol Med       Date:  1983-11       Impact factor: 7.723

7.  A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing.

Authors:  T Hökfelt; L Skirboll; J F Rehfeld; M Goldstein; K Markey; O Dann
Journal:  Neuroscience       Date:  1980       Impact factor: 3.590

8.  A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists.

Authors:  F J White; R Y Wang
Journal:  Life Sci       Date:  1984-03-19       Impact factor: 5.037

9.  Increase in brain 125I-cholecystokinin (CCK) receptor binding following chronic haloperidol treatment, intracisternal 6-hydroxydopamine or ventral tegmental lesions.

Authors:  R S Chang; V J Lotti; G E Martin; T B Chen
Journal:  Life Sci       Date:  1983-02-21       Impact factor: 5.037

10.  Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia.

Authors:  I N Ferrier; G W Roberts; T J Crow; E C Johnstone; D G Owens; Y C Lee; D O'Shaughnessy; T E Adrian; J M Polak; S R Bloom
Journal:  Life Sci       Date:  1983-08-01       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.